Identiv Inc
For the period ended Mar 31, 2024. Filed May 10, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 10, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Consolidated Financial Statements
March 31, 2024
- Basis of Presentation
The accompanying unaudited condensed consolidated financial statements include the accounts of Identiv, Inc. and its wholly owned subsidiaries (the “Company”). All intercompany balances and transactions have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements have been included. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024 or any future period. The unaudited condensed consolidated balance sheet as of December 31, 2023 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors,” and the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as amended. The accompanying unaudited condensed consolidated financial statements contain historical financial information for the periods presented and do not reflect any impact of the Stock and Asset Purchase Agreement entered into on April 2, 2024 more fully disclosed in Note 16, Subsequent Events.
- Significant Accounting Policies and Recent Accounting Pronouncements
Significant Accounting Policies
No material changes have been made to the Company's significant accounting policies disclosed in Note 2, Significant Accounting Policies and Recent Accounting Pronouncements, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as amended.
Recent Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on its financial position or results of operations upon adoption.
In November 2023, the FASB issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. Early adoption is permitted. The Company is currently evaluating the impact of the new standard on the consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU is intended to improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU’s amendments are effective for public business entities for annual periods beginning after December 15, 2024. Entities are permitted to early adopt the standard for “annual financial statements that have not yet been issued or made available for issuance.” Adoption is either prospectively or retrospectively, the Company will adopt this ASU on a prospective basis. The Company is currently evaluating the impact of the new standard on the consolidated financial statements and related disclosures.
- Revenue
Revenue Recognition
Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company enters into contracts that can include various combinations of its products, software licenses, and services, which are generally capable of being distinct and accounted for as separate performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation, generally on a relative basis using its standalone selling price. The stated contract value is generally the transaction price to be allocated to the separate performance obligations. Revenue is recognized net of any taxes collected from customers that are subsequently remitted to governmental authorities.
Nature of Products and Services
The Company derives revenues from sales of hardware products, software licenses, subscriptions, professional services, software maintenance and support, and extended hardware warranties.
Hardware Product Revenue— The Company generally has two performance obligations in arrangements involving the sale of hardware products. The first performance obligation is to transfer the hardware product (which includes software integral to the functionality of the hardware product). The second performance obligation is to provide assurance that the product complies with its agreed-upon specifications and is free from defects in material and workmanship for a period of one to three years (i.e., assurance warranty). The entire transaction price is allocated to the hardware product and is generally recognized as revenue at the time of shipment because the customer obtains control of the product at that point in time. The Company has concluded that control generally transfers at that point in time because the customer has title to the hardware, and a present obligation to pay for the hardware. None of the transaction price is allocated to the assurance warranty component, as the Company accounts for these product warranty costs in accordance with Accounting Standards Codification (“ASC”) 460, Guarantees.
Software License Revenue — The Company’s license arrangements grant customers the perpetual right to access and use the licensed software products at the outset of an arrangement. Technical support and software updates are generally made available throughout the term of the support agreement, which is generallyone tothree years. The Company accounts for these arrangements as two performance obligations: (1) the software licenses, and (2) the related updates and technical support. The software license revenue is recognized when the license is delivered to the customer or made available for download, while the software updates and technical support revenue is recognized over the term of the support contract.
Subscription Revenue — Subscription revenues consist of fees received in consideration for providing customers access to one or more of the Company’s software-as-a-service (“SaaS”) based solutions. These SaaS arrangements include access to the Company’s licensed software and, in certain arrangements, use of various hardware devices over the contract term. These SaaS arrangements do not provide the customer the right to take possession of the software supporting the subscription service, or if applicable, any hardware devices at any time during the contract period, and as such are not considered separate performance obligations. Revenue is recognized ratably on a straight-line basis over the term of the contract beginning when the service is made available to the customer. Subscription contract terms range from month-to-month tosix years in length and are billed monthly or annually.
Professional Services Revenue — Professional services revenue consists primarily of programming customization services performed relating to the integration of the Company’s software products with the customers other systems, such as human resources systems. Professional services contracts are generally billed on a time and materials basis and revenue is recognized as the services are performed.
Software Maintenance and Support Revenue — Support and maintenance contract revenue consists of the services provided to support the specialized programming applications performed by the Company’s professional services group. Support and maintenance contracts are typically billed at inception of the contract and recognized as revenue over the contract period, typically over aone-orthree-year period.
Extended Hardware Warranties Revenue — Sales of the Company’s hardware products may also include optional extended hardware warranties, which typically provide assurance that the product will continue to function as initially intended. Extended hardware warranty contracts are typically billed at inception of the contract and recognized as revenue over the respective contract period, typically overone-to-two-year periods after the expiration of the original assurance warranty.
| PerformanceObligation | When Performance Obligation isTypically Satisfied | When Payment isTypically Due | How Standalone Selling Price isTypically Estimated |
|---|---|---|---|
| Hardware products | When customer obtains control of the product (point-in-time) | Within 30-60 days of shipment | Observable in transactions without multiple performance obligations |
| Software licenses | When license is delivered to customer or made available for download, and the applicable license period has begun (point-in-time) | Within 30-60 days of the beginning of license period | Established pricing practices for software licenses bundled with software maintenance, which are separately observable in renewal transactions |
| Subscriptions | Ratably over the course of the subscription term (over time) | In advance of subscription term | Contractually stated or list price |
| Professional services | As services are performed and/or when contract is fulfilled (point-in-time) | Within 30-60 days of delivery | Observable in transactions without multiple performance obligations |
| Software maintenance and support services | Ratably over the course of the support contract (over time) | Within 30-60 days of the beginning of the contract period | Observable in renewal transactions |
| Extended hardware warranties | Ratably over the course of the support contract (over time) | Within 30-60 days of the beginning of the contract period | Observable in renewal transactions |
Significant Judgments
The Company’s contracts with customers often include promises to transfer multiple products and services to a customer. For such arrangements, the Company allocates the transaction price to each performance obligation based on its relative standalone selling price (“SSP”).
Judgment is required to determine the SSP for each distinct performance obligation in a contract. For the majority of items, the Company estimates SSP using historical transaction data. The Company uses a range of amounts to estimate SSP when it sells each of the products and services separately and needs to determine whether there is a discount to be allocated based on the relative SSP of the various products and services. In instances where SSP is not directly observable, such as when the product or service is not sold separately, the Company determines the SSP using information that may include market conditions and other observable inputs. The determination of SSP is an ongoing process and information is reviewed regularly in order to ensure SSPs reflect current information or trends.
Disaggregation of Revenue
The Company disaggregates revenue from contracts with customers based on the timing of transfer of goods or services to customers (point-in-time or over time) and geographic region based on the shipping location of the customer. The geographic regions that are tracked are the Americas, Europe and the Middle East, and Asia-Pacific regions.
Total net revenue based on the disaggregation criteria described above is as follows (in thousands):
| Three Months Ended March 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | |||||
| Point-in-Time | Over Time | Total | Point-in-Time | Over Time | Total | |
| Americas | $15,360 | $1,144 | $16,504 | $20,874 | $754 | $21,628 |
| Europe and the Middle East | 3,897 | 101 | 3,998 | 2,899 | 85 | 2,984 |
| Asia-Pacific | 1,992 | — | 1,992 | 1,385 | — | 1,385 |
| Total | $21,249 | $1,245 | $22,494 | $25,158 | $839 | $25,997 |
Contract Balances
Amounts invoiced in advance of services being provided are accounted for as deferred revenue. Nearly all of the Company’s deferred revenue balance is related to software maintenance contracts. Payment terms and conditions vary by contract type, although payment is typically due within 30 to 60 days of contract inception. In instances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined its contracts do not include a significant financing component. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing the Company’s products and services, not to receive financing from its customers.
Changes in deferred revenue during thethree months ended March 31, 2024 and 2023 were as follows (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Deferred revenue, beginning of period | $3,268 | $2,655 |
| Deferral of revenue billed in current period, net of recognition | 542 | 504 |
| Recognition of revenue deferred in prior periods | (1,085) | (714) |
| Deferred revenue, end of period | $2,725 | $2,445 |
Amounts recognized as revenue in excess of amounts billed are recorded as unbilled receivables and are included in other current assets on the condensed consolidated balance sheets. As of March 31, 2024 and December 31, 2023, the amount of unbilled receivables was immaterial.
Unsatisfied Performance Obligations
Revenue expected to be recognized in future periods related to remaining performance obligations, excluding revenue pertaining to contracts that have an original expected duration of one year or less, and contracts where revenue is recognized as invoiced, was approximately $1.5 million as of March 31, 2024. Since the Company typically invoices customers at contract inception, this amount is included in the deferred revenue balance. As of March 31, 2024, the Company expects to recognize 30% of the revenue related to these unsatisfied performance obligations during the remainder of 2024,29% during 2025, and 41% thereafter.
- Fair Value Measurements
The Company determines the fair values of its financial instruments based on a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. Under ASC 820, Fair Value Measurement and Disclosures, the fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:
Level 1 – Quoted prices (unadjusted) for identical assets and liabilities in active markets;
Level 2 – Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly; and
Level 3 – Unobservable inputs.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
As of March 31, 2024 and December 31, 2023, the only assets measured and recognized at fair value on a recurring basis were nominal cash equivalents. As of March 31, 2024 and December 31, 2023, there wereno liabilities measured and recognized at fair value on a recurring basis.
Assets and Liabilities Measured at Fair Value on a Non-recurring Basis
Certain of the Company's assets, including goodwill, intangible assets, and privately-held investments, are measured at fair value on a nonrecurring basis if impairment is indicated. Purchased intangible assets are measured at fair value primarily using discounted cash flow projections. For additional discussion of measurement criteria used in evaluating potential impairment involving goodwill and intangible assets, refer to Note 5, Goodwill and Intangible Assets.
As of March 31, 2024 and December 31, 2023, the Company had $348,000 of privately-held investments measured at fair value on a nonrecurring basis, which were classified as Level 3 assets due to the absence of quoted market prices and inherent lack of liquidity. The Company reviews its investments to identify and evaluate investments that have an indication of possible impairment. The Company adjusts the carrying value for its privately-held investments for any impairment if the fair value is less than the carrying value of the respective assets on an other-than-temporary basis. The amount of privately-held investments is included in other assets in the accompanying condensed consolidated balance sheets.
As of March 31, 2024 and December 31, 2023, there wereno liabilities that are measured and recognized at fair value on a non-recurring basis.
Assets and Liabilities Not Measured at Fair Value
The carrying amounts of the Company's accounts receivable, prepaid expenses and other current assets, accounts payable, and other accrued liabilities approximate fair value due to their short maturities. The carrying value of the Company's financial liabilities approximates fair value based upon borrowing rates currently available to the Company for loans with similar terms.
- Goodwill and Intangible Assets
Goodwill
The following table summarizes the activity in goodwill (in thousands):
| Identity | Premises | Total | |
|---|---|---|---|
| Balance as of January 1, 2023 | $3,554 | $6,636 | $10,190 |
| Currency translation adjustment | — | 2 | 2 |
| Balance as of March 31, 2023 | $3,554 | $6,638 | $10,192 |
| Balance as of January 1, 2024 | $3,554 | $6,664 | $10,218 |
| Currency translation adjustment | — | (26) | (26) |
| Balance as of March 31, 2024 | $3,554 | $6,638 | $10,192 |
In accordance with ASC 350, Intangibles – Goodwill and Other, the Company tests goodwill for impairment on an annual basis, in the fourth quarter, or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company performs an initial assessment of qualitative factors to determine whether the existence of events and circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. In performing the qualitative assessment, the Company identifies and considers the significance of relevant key factors, events, and circumstances that affect the fair value of its reporting units. These factors include external factors such as macroeconomic, industry, and market conditions, as well as entity-specific factors, such as actual and planned financial performance. If, after assessing the totality of relevant events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit exceeds its carrying value and there is no indication of impairment, no further testing is performed; however, if the Company concludes otherwise, then the Company will perform the quantitative impairment test which compares the estimated fair value of the reporting unit to its carrying value, including goodwill. If the carrying amount of the reporting unit is in excess of its fair value, an impairment loss would be recorded in the condensed consolidated statements of comprehensive loss. During the three months ended March 31, 2024 and 2023, the Company notedno indicators of goodwill impairment and concluded no further testing was necessary.
Intangible Assets
The following table summarizes the gross carrying amount and accumulated amortization for intangible assets resulting from acquisitions (in thousands):
| Developed · Customer | |||||||
|---|---|---|---|---|---|---|---|
| Trademarks · Technology · Relationships · Total | |||||||
| Amortization period (in years) | 5 | 10 – 12 | 4 – 12 | ||||
| Gross carrying amount as of March 31, 2024 | $760 | $9,088 | $15,742 | $25,590 | |||
| Accumulated amortization | (760) | (7,220) | (13,615) | (21,595) | |||
| Intangible assets, net as of March 31, 2024 | $— | $1,868 | $2,127 | $3,995 | |||
| Gross carrying amount as of December 31, 2023 | $760 | $9,098 | $15,748 | $25,606 | |||
| Accumulated amortization | (760) | (7,110) | (13,485) | (21,355) | |||
| Intangible assets, net as of December 31, 2023 | $— | $1,988 | $2,263 | $4,251 | |||
Each period, the Company evaluates the estimated remaining useful lives of purchased intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. If a revision to the remaining period of amortization is warranted, amortization is prospectively adjusted over the remaining useful life of the intangible asset. Intangible assets subject to amortization are amortized on a straight-line basis over their useful lives as indicated in the table above. The Company performs an evaluation of its amortizable intangible assets for impairment at the end of each reporting period. The Company didnot identify any impairment indicators during thethree months ended March 31, 2024.
The following table summarizes the amortization expense included in the condensed consolidated statements of comprehensive income (loss) for thethree months ended March 31, 2024 and 2023 (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cost of revenue | $110 | $111 |
| Selling and marketing | 130 | 155 |
| Total | $240 | $266 |
The estimated annual future amortization expense for purchased intangible assets with definite lives as of March 31, 2024 was as follows (in thousands):
| 2024 (remaining nine months) | $721 |
| 2025 | 961 |
| 2026 | 961 |
| 2027 | 961 |
| 2028 | 391 |
| Total | $3,995 |
- Balance Sheet Components
The Company’s inventories are stated at the lower of cost or net realizable value. Inventories consist of (in thousands):
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Raw materials | $14,255 | $15,122 |
| Work-in-progress | — | 5 |
| Finished goods | 14,205 | 13,585 |
| Total | $28,460 | $28,712 |
Property and equipment, net consists of (in thousands):
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Building and leasehold improvements | $1,999 | $2,203 |
| Furniture, fixtures and office equipment | 1,064 | 1,017 |
| Plant and machinery | 18,957 | 18,920 |
| Purchased software | 855 | 836 |
| Total | 22,875 | 22,976 |
| Accumulated depreciation | (14,043) | (13,656) |
| Property and equipment, net | $8,832 | $9,320 |
The Company recorded depreciation expenses of $0.5 million and $0.4 million during thethree months ended March 31, 2024 and 2023, respectively.
Other accrued expenses and liabilities consist of (in thousands):
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Accrued professional fees | $449 | $441 |
| Accrued warranties | 301 | 378 |
| Other accrued expenses | 1,601 | 1,375 |
| Total | $2,351 | $2,194 |
- Financial Liabilities
The Company’s financial liabilities consist of (in thousands):
| March 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| Revolving loan facility | $10,000 | $10,000 |
| Less: Unamortized debt issuance costs | (106) | (51) |
| Financial liabilities, net of debt issuance costs | $9,894 | $9,949 |
On February 8, 2017, the Company entered into a Loan and Security Agreement (as amended or amended and restated from time to time, the “Loan Agreement”) with East West Bank (“EWB”). Following subsequent amendments, on April 14, 2022, the Company and EWB amended the Loan Agreement replacing the $20.0 million revolving loan facility subject to a borrowing base with a non-formula revolving loan facility with no borrowing base requirement and a maturity date of February 8, 2023. In addition, the interest rate was lowered from prime to prime minus 0.25% (interest rate as of March 31, 2024 was 8.50%), and certain financial covenants were amended. On February 8, 2023, the Company entered into an amendment (the "Fourth Amendment") to the Loan Agreement. The Fourth Amendment amends the Loan Agreement to, among other things, extend the maturity date to February 8, 2025, and amend certain financial covenants.
The Loan Agreement contains customary representations and warranties and customary affirmative and negative covenants, including, limits or restrictions on the Company’s ability to incur liens, incur indebtedness, make certain restricted payments (including dividends), merge or consolidate and dispose of assets, as well as other financial covenants. The Company’s obligations under the Loan Agreement are collateralized by substantially all of its assets. The Company was not in compliance with a financial covenant under the Loan Agreement as of March 31, 2024, which non-compliance was waived by EWB on May 6, 2024.
- Income Taxes
The Company conducts business globally and, as a result, files federal, state and foreign tax returns. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreement with a tax authority at any time. While the Company has accrued for amounts it believes are the probable outcomes, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the condensed consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal.
The Company applies the provisions of, and accounted for uncertain tax positions, in accordance with ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. It prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.
The Company generally is no longer subject to tax examinations for years prior to 2018. However, if loss carryforwards of tax years prior to 2017 are utilized in the U.S., these tax years may become subject to investigation by the tax authorities. While timing of the resolution and/or finalization of tax audits is uncertain, the Company does not believe that its unrecognized tax benefits would materially change in the next 12 months.
- Stockholders’ Equity
Series B Convertible Preferred Stock Dividend Accretion
The following table summarizes Series B convertible preferred stock and the accretion of dividend activity for thethree months ended March 31, 2024 and 2023 (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Series B Convertible Preferred Stock: | ||
| Balance at beginning of period | $26,589 | $25,323 |
| Cumulative dividends on Series B convertible preferred stock | 248 | 313 |
| Balance at end of period | $26,837 | $25,636 |
| Number of Common Shares Issuable Upon Conversion: | ||
| Number of shares at beginning of period | 6,647 | 6,331 |
| Cumulative dividends on Series B convertible preferred stock | 62 | 78 |
| Number of shares at end of period | 6,709 | 6,409 |
Based on the current conversion price, the outstanding shares, including the accretion of dividends, of Series B convertible preferred stock as of March 31, 2024 would be convertible into 6,709,359 shares of the Company’s common stock. However, the conversion rate will be subject to adjustment in certain instances, such as if the Company issues shares of its common stock at a price less than $4.00 per common share, subject to a minimum conversion price of $3.27 per share. As of March 31, 2024, none of the contingent conditions to adjust the conversion rate had been met.
Each share of Series B convertible preferred stock is entitled to a cumulative annual dividend of 5% for the first six years following the issuance of such share and 3% for each year thereafter, with the Company retaining the option to settle each year’s dividend after the 10th year in cash. The dividends accrue and are payable in kind upon such time as the shares convert into the Company’s common stock. In general, the shares are not entitled to vote except in certain limited cases, including in change of control transactions where the expected price per share distributable to the Company’s stockholders is expected to be less than $4.00 per share. The Certificate of Designation with respect to the Series B convertible preferred stock further provides that in the event of, among other things, any change of control, liquidation or dissolution of the Company, the holders of the Series B convertible preferred stock will be entitled to receive, on a pari passu basis with the holders of the common stock, the same amount and form of consideration that the holders of the Company’s common stock receive (on an as-if-converted-to-common-stock basis and without regard to the Beneficial Ownership Limitation (as defined in the Certificate of Designation) applicable to the Series B convertible preferred stock).
Common Stock Reserved for Future Issuance
Common stock reserved for future issuance as of March 31, 2024 was as follows:
| Exercise of outstanding stock options, vesting of restricted stock units ("RSUs"), and issuance of RSUs vested but not released | 1,304,248 |
|---|---|
| Employee Stock Purchase Plan | 293,888 |
| Shares of common stock available for grant under the 2011 Plan | 286,899 |
| Shares of common stock issuable upon conversion of Series B convertible preferred stock | 7,541,449 |
| Total | 9,426,484 |
- Stock-Based Compensation
Stock Incentive Plan
The Company maintains a stock-based compensation plan, the 2011 Incentive Compensation Plan, as amended (the “2011 Plan”), to attract, motivate, retain and reward employees, directors and consultants by providing its Board or a committee of the Board the discretion to award equity incentives to these persons.
Stock Options
A summary of stock option activity for thethree months ended March 31, 2024 is as follows:
| Number Outstanding | Weighted Average ExercisePrice per Share | Weighted AverageRemainingContractual Term (Years) | AggregateIntrinsic Value | |
|---|---|---|---|---|
| Balance as of January 1, 2024 | 494,960 | $4.99 | 2.23 | $1,725,985 |
| Granted | — | — | ||
| Cancelled or Expired | (7,500) | 8.97 | ||
| Exercised | — | — | ||
| Balance as of March 31, 2024 | 487,460 | $4.93 | 2.01 | $1,583,118 |
| Vested or expected to vest as of March 31, 2024 | 487,460 | $4.93 | 2.01 | $1,583,118 |
| Exercisable as of March 31, 2024 | 487,460 | $4.93 | 2.01 | $1,583,118 |
The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock as of March 31, 2024 and the exercise price of in-the-money stock options multiplied by the number of such stock options.
The following table summarizes information about stock options outstanding as of March 31, 2024:
| Stock Options Outstanding · Stock Options Exercisable | |||||
|---|---|---|---|---|---|
| Range of Exercise Prices | NumberOutstanding | WeightedAverageRemainingContractual Life(Years) | WeightedAverageExercisePrice | NumberExercisable | WeightedAverageExercisePrice |
| $4.36 - $7.20 | 446,460 | 2.17 | $4.37 | 446,460 | $4.37 |
| $10.93 - $16.40 | 41,000 | 0.25 | 10.93 | 41,000 | 10.93 |
| $4.36 - $16.40 | 487,460 | 2.01 | $4.93 | 487,460 | $4.93 |
As of March 31, 2024, there wasno unrecognized stock-based compensation expense related to stock options.
Restricted Stock Units
The following is a summary of RSU activity for thethree months ended March 31, 2024:
| NumberOutstanding | Weighted AverageFair Value | |
|---|---|---|
| Unvested as of January 1, 2024 | 730,062 | $11.17 |
| Granted | 127,919 | 8.63 |
| Vested | (106,761) | 10.16 |
| Forfeited | — | — |
| Unvested as of March 31, 2024 | 751,220 | $10.88 |
| RSUs vested but not released | 65,568 | $10.72 |
The fair value of the Company’s RSUs is calculated based upon the fair market value of the Company’s common stock at the date of grant. As of March 31, 2024, there was $7.0 million of unrecognized compensation expense related to unvested RSUs granted, which is expected to be recognized over a weighted average period of 2.3 years. No tax benefit was realized from RSUs for thethree months ended March 31, 2024.
Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense related to stock options and RSUs included in the condensed consolidated statements of comprehensive income (loss) for thethree months ended March 31, 2024 and 2023 (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cost of revenue | $47 | $45 |
| Research and development | 182 | 202 |
| Selling and marketing | 264 | 293 |
| General and administrative | 526 | 450 |
| Total | $1,019 | $990 |
Restricted Stock Unit Net Share Settlements
During the three months ended March 31, 2024 and 2023, the Company repurchased 32,608 and 24,812 shares, respectively, of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.
- Net Loss per Common Share
Basic net loss per common share is computed by dividing net loss available to common stockholders during the period by the weighted average number of common shares outstanding during that period. Diluted net loss per common share is impacted by equity instruments considered to be potential common shares, if dilutive, computed using the treasury stock or the if-converted method of accounting. Dilutive potential common share equivalents are excluded from the computation of net loss per share in loss periods, as their effect would be antidilutive.
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Basic net loss per common share: | ||
| Numerator: | ||
| Net loss | $(4,558) | $(2,719) |
| Less: accretion of Series B convertible preferred stock dividends | (248) | (313) |
| Net loss available to common stockholders | $(4,806) | $(3,032) |
| Denominator: | ||
| Weighted average common shares outstanding - basic and diluted | 23,368 | 22,794 |
| Net loss per common share - basic and diluted | $(0.21) | $(0.13) |
The following common stock equivalents have been excluded from diluted net loss per share for thethree months ended March 31, 2024 and 2023 because their inclusion would have been anti-dilutive (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Shares of common stock subject to outstanding RSUs | 751 | 873 |
| Shares of common stock subject to outstanding PSUs | — | 40 |
| Shares of common stock subject to outstanding stock options | 487 | 506 |
| Shares of common stock subject to outstanding warrants | — | 275 |
| Shares of common stock issuable upon conversion of Series B convertible preferred stock | 6,709 | 6,409 |
| Total | 7,947 | 8,103 |
- Segment Reporting, Geographic Information, and Concentration of Credit Risk
Segment Reporting
ASC 280, Segment Reporting establishes standards for the reporting by public business enterprises of information about operating segments, products and services, geographic areas, and major customers. The method for determining what information to report is based on the way management organizes the operating segments within the Company for making operating decisions and assessing financial performance. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses and about which separate financial information is available to its chief operating decision makers (“CODM”). The Company’s CODM is its Chief Executive Officer.
The CODM reviews financial information and business performance for each operating segment. The Company evaluates the performance of its operating segments at the revenue and gross profit levels. The Company does not report total assets, capital expenditures or operating expenses by operating segment as such information is not used by the CODM for purposes of assessing performance or allocating resources.
Net revenue and gross profit information by segment for thethree months ended March 31, 2024 and 2023 are as follows (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Identity: | ||
| Net revenue | $12,835 | $14,678 |
| Gross profit | 2,834 | 3,079 |
| Gross profit margin | 22% | 21% |
| Premises: | ||
| Net revenue | 9,659 | 11,319 |
| Gross profit | 5,558 | 6,132 |
| Gross profit margin | 58% | 54% |
| Total: | ||
| Net revenue | 22,494 | 25,997 |
| Gross profit | 8,392 | 9,211 |
| Gross profit margin | 37% | 35% |
| Operating expenses: | ||
| Research and development | 3,011 | 2,707 |
| Selling and marketing | 5,302 | 6,097 |
| General and administrative | 4,252 | 2,948 |
| Restructuring and severance | 22 | 191 |
| Total operating expenses: | 12,587 | 11,943 |
| Loss from operations | (4,195) | (2,732) |
| Non-operating income (expense): | ||
| Interest expense, net | (87) | (50) |
| Foreign currency gains (losses), net | (256) | 89 |
| Loss before income tax provision | $(4,538) | $(2,693) |
Geographic Information
Geographic net revenue is based on the customer’s ship-to location. Information regarding net revenue by geographic region for the three months ended March 31, 2024 and 2023 is as follows (in thousands):
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Americas | $16,504 | $21,628 |
| Europe and the Middle East | 3,998 | 2,984 |
| Asia-Pacific | 1,992 | 1,385 |
| Total | $22,494 | $25,997 |
| As percentage of net revenue: | ||
| Americas | 73% | 83% |
| Europe and the Middle East | 18% | 12% |
| Asia-Pacific | 9% | 5% |
| Total | 100% | 100% |
Concentration of Credit Risk
One customer accounted for 11% of net revenue for the three months ended March 31, 2024. No customer accounted for more than 10% of net revenue for the three months ended March 31, 2023. No customer accounted for 10% or more of net accounts receivable as of March 31, 2024 or December 31, 2023.
Long-lived assets by geographic location as of March 31, 2024 and December 31, 2023 are as follows (in thousands):
| March 31,2024 | December 31,2023 | |
|---|---|---|
| Property and equipment, net: | ||
| Americas | $667 | $711 |
| Europe and the Middle East | 500 | 519 |
| Asia-Pacific | 7,665 | 8,090 |
| Total property and equipment, net | $8,832 | $9,320 |
| Operating lease ROU assets: | ||
| Americas | $2,623 | $2,836 |
| Europe and the Middle East | 316 | 371 |
| Asia-Pacific | 1,817 | 2,007 |
| Total operating lease right-of-use assets | $4,756 | $5,214 |
- Restructuring and Severance
During the three months ended March 31, 2024 and 2023, restructuring expenses consisted of severance related costs of $22,000 and $191,000, respectively.
- Leases
The Company’s leases consist primarily of operating leases for administrative office space, research and development facilities, manufacturing facilities, and sales offices in various countries around the world. The Company determines if an arrangement is a lease at inception. Some lease agreements contain lease and non-lease components, which are accounted for as a single lease component. Total rent expense was $0.6 million and $0.4 million for thethree months ended March 31, 2024 and 2023, respectively.
Initial lease terms are determined at commencement and may include options toextend or terminate the lease when it is reasonably certain the Company will exercise the option. Remaining lease terms range fromone tofour years, some of which include options to extend for up tofive years. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the lease commencement date.
The table below reconciles the undiscounted cash flows for the first five years and the total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of March 31, 2024 (in thousands):
| 2024 (remaining nine months) | $1,475 |
| 2025 | 1,765 |
| 2026 | 1,347 |
| 2027 | 858 |
| 2028 | 23 |
| Total minimum lease payments | 5,468 |
| Less: amount of lease payments representing interest | (504) |
| Present value of future minimum lease payments | 4,964 |
| Less: current liabilities under operating leases | (1,655) |
| Long-term operating lease liabilities | $3,309 |
As of March 31, 2024, the weighted average remaining lease term for the Company’s operating leases was 3.1 years, and the weighted average discount rate used to determine the present value of the Company’s operating leases was 7.0%.
Cash paid for amounts included in the measurement of operating lease liabilities was $0.5 million and $0.4 million for the three months ended March 31, 2024 and 2023, respectively.
- Commitments and Contingencies
The following table summarizes the Company’s principal contractual commitments, excluding operating leases, as of March 31, 2024 (in thousands):
| PurchaseCommitments · OtherContractualCommitments · Total | |||
|---|---|---|---|
| 2024 (remaining nine months) | $21,597 | $151 | $21,748 |
| 2025 | 5,320 | 31 | 5,351 |
| 2026 | 2,729 | 9 | 2,738 |
| 2027 | 3,500 | 1 | 3,501 |
| Total | $33,146 | $192 | $33,338 |
Purchase commitments for inventories are highly dependent upon forecasts of customer demand. Due to the uncertainty in demand from its customers, the Company may have to change, reschedule, or cancel purchases or purchase orders from its suppliers. These changes may lead to vendor cancellation charges on these purchases or contractual commitments.
The following table summarizes the Company’s warranty accrual account activity during thethree months ended March 31, 2024 and 2023:
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Balance at beginning of period | $378 | $345 |
| Credited to costs and expenses | (77) | (5) |
| Cost of warranty claims | — | 1 |
| Balance at end of period | $301 | $341 |
The Company provides warranties on certain product sales for periods ranging from 12 to 36 months, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically, the warranty accrual and the expense amounts have been immaterial.
- Subsequent Events
On April 2, 2024, the Company entered into a Stock and Asset Purchase Agreement (the “Purchase Agreement”) with Hawk Acquisition, Inc., a Delaware corporation (“Buyer”) and a wholly-owned subsidiary of Vitaprotech SAS, a French société par actions simplifiée and provider of security solutions (“Vitaprotech”). Upon the terms and subject to the conditions set forth in the Purchase Agreement, at the closing of the transactions contemplated thereby, the Company will sell its physical security, access card, and identity reader operations and assets, including all outstanding shares of Identiv Private Limited, its wholly-owned subsidiary (the “Physical Security Business”), to Buyer in exchange for $145.0 million in cash (the “Purchase Price”), subject to customary adjustments set forth in the Purchase Agreement, and the assumption by Buyer of certain liabilities related to the Physical Security Business (collectively, the “Asset Sale”).
The completion of the Asset Sale and the other transactions contemplated by the Purchase Agreement (the “Closing”) is subject to customary conditions, including, (1) the approval of the Asset Sale by the Company’s stockholders, (2) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), (3) the absence of any order that has the effect of enjoining or otherwise prohibiting the completion of the Asset Sale, (4) each party’s representations and warranties being true and correct as of the Closing, (5) each party’s material compliance with agreements, covenants and conditions, (6) obtaining clearance from the Committee on Foreign Investment in the United States (“CFIUS”), (7) obtaining approval under the United Kingdom National Security and Investment Act 2021 (the “NSI Act”), and (8) delivery of the Purchase Price. The Closing is not subject to the approval of Buyer’s stockholders or the receipt of financing by Buyer. Certain of Buyer’s obligations under the Purchase Agreement are guaranteed by Vitaprotech.
The Purchase Agreement includes customary representations, warranties and covenants of the Company and Buyer, including covenants to use their respective reasonable best efforts to consummate the transactions contemplated by the Purchase Agreement. Between the date of execution of the Purchase Agreement and the Closing, the Company has agreed to conduct its and its subsidiaries’ business in the ordinary course of business and in a manner consistent with past practice and to comply with certain operating covenants.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.